The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss

Farnesoid X receptor (FXR, NR1H4) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. Since the role of FXR in osteoclast differentiation remains ill-defined, we investigated the biological function of FXR on osteoclastogenesis, using FXR-deficient mice. We dem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zheng, Ting, Kang, Ju-Hee, Sim, Jung-Sun, Kim, Jung-Woo, Koh, Jeong-Tae, Shin, Chan Soo, Lim, Hyungsik, Yim, Mijung
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652726/
https://ncbi.nlm.nih.gov/pubmed/29100332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20576
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados